No Sales BS, please. Just the facts, ma'am.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
POWER HOUR. Slightly above 20 day avg volume and just peeking green. Let's breakout past .43.
You could be get your wish there and I'm right there with you.
And there should be zero connections between shorts and OTCm in a just world. Heck, I'd settle for a slightly more reasonable world.
That a Canadian stock market right?
Nice informative video. Different market but the technology is nicely summarized.
Send that guy back to Troll Academy ;-D
Lateral move on avg. Vol.
OK I think it's safe to say now that we've hit a bottom. Time to rebuild.
Actually for all the volume and a little pressure on the bid this week LXGTF is holding quite strong. We are much closer to the 52 week high (0.48) than the 52 week low (0.25). Arithmetic.
That's the part that sucks. 3rd party is responsible but FVRD has to suffer the consequences. And OTCm as usual exceptionally drag-assy to rectify the situation "30 days"
Hi Dapper, its still in clinical tests. Not on the market.
Maybe it's a new trend then because they did the same thing to RAKR for about 45 days. It just came off about a week ago. Same thing it was Pink Current the whole time. We all wondered why it was CE and we have no idea what changed for it be removed either. Except there were definitely a lot of shorts hanging around the board. 1 even slipped up and claimed credit in part for the CE.
Brainfart make that LXGTF
HeartSentry technology is backed by 15 years of patented peer reviewed research at Berkeley labs a 13 time Nobel prize winning lab.
Endothelial function is the best indicator of impending heart attack or stroke but the current diagnostic methods are not affordable and inconvenient.
HeartSentry technology is the best diagnostic solution available for measuring endothelial function.
2018 should be a massive year for FVRD if FDA clearance materializes.
That was a big reset yesterday. Very curious to see how much FVRD can recover today.
Seems like the Dutch Military contracts has the greatest potential to impact revenues in the long run. Would like to hear how that's developing.
Well let's see what RAKR has in store today.
Seems to be arching back to the .43 support levels.
Looks like we end down a penny on 342K in volume. Not the best day but not bad really. LXGTF has some strong support from Longs and float can't wander far.
Let's see how this shakes out as power hour winds down.
Sounds likely. I'm not an MD, but proximity to the heart seems the key factor.
Yeah for some nice volume with pressure on the Buy LXGtF is not slipping much. Which tells me sidelined investors had been waiting for just such an opportunity to pick up some raining discounts.
Down a penny. Time to whack that ask!
Down a penny. Time to whack that ask!
I never noticed that HeartSentry measures endothelial function in larger arteries. The graphic lists it as an advantage over the competition. I wonder exactly how it's an advantage? Is it because the arteries going to the heart are larger?
What's a simile. Some kind of emoji? ;-D
That's the time to make money.
Truth. Great post.
Lots of churn, churn, churn today. Catch those goodies coming out the pinata.
LXGTF cyber Monday must have depleted some accounts. Would like to see that volume increase.
Not outside the realm of probability. Hence the market interest demonstrated by all the quiet accumulation and volume.
Exactly.
A ride UP the lazy river with the wind at my back. LoL
Oooh that would be funny but so many of those Victorian urchins did die in the chimneys. Haven't you ever read Oliver Twist? Aaaaand I'm way off topic. I'll stop. Sad urchins. Go LXGTF!
50 Billion industry, 15 years of patented peer reviewed technology from a 13 time Nobel prize winning laboratory, no credible competition, and FDA 510k fast tracked to market with a diagnostic solution to stop the modern world's number one killer cold in its tracks. LXGTF is a hidden gemstone.
Like trading your water wings for a jetski haha. OK actually I'm exaggerating now. But LXGTF definitely hands down superior to the competition.
Time only seems to do good things for the LXGTF chart.